Introduction: Who Should Undergo Diagnostics and When

Anyone who notices an expanding, unusual rash after spending time outdoors should consider seeking medical evaluation, especially if they live in or have visited areas where Lyme disease is common. The diagnosis of erythema migrans is primarily a clinical one, meaning that doctors can often make it based on the appearance of the rash and your recent history, without necessarily needing laboratory confirmation.^[1][2]

You should seek medical attention if you develop an expanding red area on your skin anywhere from one day to one month after possible exposure to ticks. This is particularly important if you’ve been in wooded areas, tall grass, or places where ticks are known to live. The rash typically appears between three and thirty days after a tick bite, with most people noticing it within seven to ten days.^[4][5]

Early diagnosis is crucial because Lyme disease is much easier to treat in its early stages. Without treatment, the infection can spread through your body and affect your joints, heart, and nervous system. The good news is that when Lyme disease is caught early and treated with appropriate antibiotics, most people recover rapidly and completely.^[8]

Not everyone who gets Lyme disease will remember being bitten by a tick. Ticks that carry the disease are very small—nymphs (young ticks) are about the size of a poppy seed, while adult ticks are roughly the size of a sesame seed. Because they’re so tiny and their bites are usually painless, many people never notice them on their body.^[6]

People who spend time outdoors in tick-prone areas should be especially vigilant. This includes those who work or recreate in wooded environments, gardens, or areas with tall grass and brush. Children are also at risk, particularly when ticks hide in their hair, behind ears, or along the hairline where they’re harder to spot.^[6]

Diagnostic Methods for Identifying Erythema Migrans

Clinical Diagnosis Based on Rash Appearance

The erythema migrans rash is so distinctive that it’s the only manifestation of Lyme disease in the United States that allows doctors to make a diagnosis based solely on clinical observation, without needing laboratory confirmation. This means that if you have the characteristic rash and have recently been in an area where Lyme disease occurs, your doctor can confidently diagnose Lyme disease and begin treatment immediately.^[2]

The rash has several characteristic features that help doctors identify it. First, it expands rapidly—typically growing two to three centimeters per day and eventually reaching anywhere from five to seventy centimeters in diameter. About half of all erythema migrans rashes grow larger than sixteen centimeters. This speed and extent of expansion is one of the most distinctive features that sets it apart from other skin conditions.^[2]

The shape of the rash is usually circular or oval, appearing red or bluish in color. While many people have heard of the “bull’s-eye” appearance with a clear center surrounded by a red ring, this pattern actually occurs in only about nineteen percent of cases in areas of the United States where Lyme disease is common. In Europe, the bull’s-eye pattern is more frequent, appearing in about seventy-nine percent of cases. Most of the time in the United States, the rash is simply a solid, evenly red or bluish expanding patch.^[2][3]

The texture and sensation of the rash also provide diagnostic clues. The rash may feel warm to the touch and sometimes has an elevated or darker center. However, unlike many other skin problems, erythema migrans is usually not itchy and is rarely tender or painful. This lack of discomfort can actually be problematic because it means people might not notice the rash, especially if it’s in a location that’s hard to see, like the middle of the back or behind the knee.^[2][6]

The location where the rash appears is typically at or near the site where an infected tick bit you. Common locations include areas near skin folds such as the armpit, groin, or back of the knee; on the trunk; under clothing straps; or in children, in the hair, ears, or neck. However, as the infection spreads through the body, some people develop multiple rashes at different locations, even though they may have only been bitten by one tick.^[2][5]

Physical Examination and Medical History

When you visit a doctor with a suspected erythema migrans rash, they will conduct a thorough physical examination and take a detailed medical history. The examination involves carefully looking at the rash, measuring its size, noting its characteristics, and checking for any additional rashes on other parts of your body. Your doctor will also examine you for other early signs of Lyme disease.^[6]

During the medical history portion of your visit, your doctor will ask about your recent activities and whether you’ve been in areas where ticks are commonly found. They’ll want to know when you first noticed the rash, whether it has grown, and if you remember being bitten by a tick. They’ll also ask about any symptoms you’ve experienced, such as fever, headache, fatigue, muscle aches, joint pain, chills, or swollen lymph nodes—all of which can accompany the rash in early Lyme disease.^[6][7]

It’s important to note that many people notice a small bump or area of redness immediately after a tick bite. This initial reaction usually goes away within a few days and is not a sign of Lyme disease—it’s simply a normal response to the bite itself. The true erythema migrans rash develops later, typically between three and thirty days after the bite, and continues to expand rather than fading away quickly.^[4]

Distinguishing Erythema Migrans from Other Skin Conditions

One of the challenges in diagnosing erythema migrans is that several other skin conditions can look similar, at least initially. Doctors need to consider and rule out these alternative explanations for your rash. Common conditions that can be confused with erythema migrans include insect bite hypersensitivity reactions, fixed drug reactions, ringworm, pityriasis rosea, granuloma annulare, and hives.^[1]

Insect bite hypersensitivity reactions can cause large, itchy rashes that result from an allergic response to a bite. However, these are usually more itchy than erythema migrans and don’t expand as rapidly or to the same extent. Fixed drug reactions appear after someone takes a medication and reappear in the same location each time that medication is taken. Ringworm, which is actually a fungal infection despite its name, can create ring-shaped rashes but typically has a scaly appearance and is itchier than erythema migrans.^[1]

Doctors use several features to distinguish erythema migrans from these other conditions. The continuous expansion of the rash over days and weeks, its typical lack of itching or pain, its appearance following possible tick exposure in an endemic area, and the presence of accompanying flu-like symptoms all point toward Lyme disease rather than these other skin conditions.^[3]

In areas where Southern tick-associated rash illness (STARI) occurs—primarily in southeastern and south-central states—the diagnostic picture becomes even more complex. STARI is caused by bites from a different type of tick (the lone star tick rather than the blacklegged tick) and produces a rash that looks nearly identical to erythema migrans. Fortunately, both conditions respond to the same antibiotic treatment, so the initial management is similar.^[2]

Role of Laboratory Testing in Diagnosis

When a typical erythema migrans rash is present along with appropriate exposure history, laboratory testing is generally not necessary to diagnose Lyme disease. The clinical diagnosis is considered sufficient to begin treatment. In fact, standard guidelines state that routine laboratory testing is not recommended for people with a characteristic erythema migrans rash and appropriate exposure history.^[2][12]

There are good reasons why lab tests aren’t typically used in early Lyme disease. Blood tests look for antibodies that your immune system makes in response to the bacteria. However, it takes time for your body to produce these antibodies—usually several weeks. If you get tested too early, the results may be negative even though you have the infection. This is called a false negative result, and it could lead to delayed treatment if doctors rely on the test instead of the clinical picture.^[7]

Laboratory testing becomes more important when the diagnosis is uncertain—for example, if someone has symptoms suggesting Lyme disease but doesn’t have the characteristic rash, or if they live in an area where Lyme disease is not common. In these situations, blood tests can help confirm whether someone has been infected with the bacteria that causes Lyme disease.^[12]

When laboratory testing is performed, doctors typically use a two-step process. The first test is called an ELISA test (enzyme-linked immunosorbent assay), which screens for antibodies against Lyme disease bacteria. If this test is positive or equivocal, a second, more specific test called a Western blot is performed to confirm the results. This two-step approach helps reduce false positive results.^[16]

Diagnostics for Clinical Trial Qualification

When erythema migrans is being studied in clinical trials, the diagnostic criteria become more standardized and rigorous to ensure that all participants truly have Lyme disease. Clinical trials testing new treatments for Lyme disease typically require specific diagnostic criteria for enrollment, which may differ slightly from routine clinical practice.^[8]

For clinical trials focused on early Lyme disease, the presence of an erythema migrans rash is often a key enrollment criterion. However, researchers usually define specific characteristics the rash must have. For example, many trials require that the rash be at least five centimeters (about two inches) in diameter. This size requirement helps ensure that the lesion is truly erythema migrans rather than a simple reaction to a tick bite.^[11]

Clinical trials may also require confirmation of potential exposure to ticks. This might include documentation that the patient lives in or has recently traveled to an area where Lyme disease is endemic (commonly occurring). Some trials require that the rash has been present for a certain period—long enough to demonstrate the characteristic expansion but not so long that the patient has developed complications.^[11]

Unlike routine clinical practice, some clinical trials do include laboratory testing as part of the qualification process. This might involve blood tests at the time of enrollment (even though they may be negative in early disease) and follow-up testing later to document that the patient did indeed have an immune response to Lyme disease bacteria. These tests help researchers confirm their diagnoses and analyze outcomes.^[9]

Clinical trials may exclude patients who have certain characteristics or conditions. For example, trials might exclude people who have already started antibiotic treatment, those with certain allergies to the antibiotics being studied, pregnant women, or people with other medical conditions that could interfere with the study. Age restrictions are also common, with separate trials sometimes conducted for children and adults.^[8][9]

Documentation in clinical trials is typically more extensive than in regular medical care. Researchers often photograph the rash, carefully measure it, and track how it changes over time. They may record detailed information about its color, texture, whether it’s warm to the touch, and any associated symptoms. This careful documentation helps ensure the accuracy of the diagnosis and provides valuable data about how erythema migrans appears and evolves.^[8]

For trials evaluating new diagnostic tests rather than treatments, the qualification criteria focus on ensuring that participants represent a range of disease stages and presentations. These trials might enroll people with confirmed erythema migrans, people with suspected but unconfirmed Lyme disease, and healthy controls who have not been exposed to Lyme disease. Having these different groups allows researchers to test how well a new diagnostic approach can distinguish between infected and non-infected individuals.^[11]